Table 2. Detection frequencies of HPgV by sequence library screening and PCR*.
| Diagnostic method | Diagnoses and characteristics | No. tested | No. (%) HHpgV-1+ | No. (%) HPgV+ |
|---|---|---|---|---|
| Bioinformatics | ||||
| HIV+ | 36 | 0 | 3 (8.3) | |
| HIV+/HCV+/PWID | 30 | 0 | 3 (10.0) | |
|
|
HCV+/PWID |
120 |
2 (1.7) |
14 (11.6) |
| PCR | ||||
| Hemophilia† | 195 | 1 (0.5) | 18 (9.2) | |
| Control group‡ | 50 | 0 | 1 (2.0) |
*HPgV, human pegivirus; HHpgV, human hepegivirus; +, positive;HCV, hepatitis C virus; PWID, persons who inject drugs. †Previously exposed to virally inactivated factor VIII/IX; all seropositive for HCV. ‡No history of parenteral exposure; HIV-1 and HCV negative.